首页> 美国卫生研究院文献>Antimicrobial Agents and Chemotherapy >Antimicrobial Susceptibilities of Aerobic and Facultative Gram-Negative Bacilli from Intra-abdominal Infections in Patients from Seven Regions in China in 2012 and 2013
【2h】

Antimicrobial Susceptibilities of Aerobic and Facultative Gram-Negative Bacilli from Intra-abdominal Infections in Patients from Seven Regions in China in 2012 and 2013

机译:2012年和2013年中国七个地区患者腹腔内需氧和兼性革兰阴性杆菌的药敏试验

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

To evaluate the antimicrobial susceptibility of Gram-negative bacilli that caused hospital-acquired and community-acquired intra-abdominal infections (IAIs) in China between 2012 and 2013, we determined the susceptibilities to 12 antimicrobials and the extended-spectrum β-lactamase (ESBL) statuses of 3,540 IAI isolates from seven geographic areas in China in a central laboratory using CLSI broth microdilution and interpretive standards. Most infections were caused by Escherichia coli (46.3%) and Klebsiella pneumoniae (19.7%). Rates of ESBL-producing E. coli (P = 0.031), K. pneumoniae (P = 0.017), and Proteus mirabilis (P = 0.004) were higher in hospital-acquired IAIs than in community-acquired IAIs. Susceptibilities of enterobacteriaceae to ertapenem, amikacin, piperacillin-tazobactam, and imipenem were 71.3% to 100%, 81.3% to 100%, 64.7% to 100%, and 83.1% to 100%, respectively, but imipenem was ineffective against P. mirabilis (<20%). Although most ESBL-positive hospital-acquired isolates were resistant to third- and fourth-generation cephalosporins, the majority were susceptible to cefoxitin (47.9% to 83.9%). Susceptibilities of ESBL-positive isolates to ampicillin-sulbactam (<10%) were low, whereas susceptibilities to ciprofloxacin (0% to 54.6%) and levofloxacin (0% to 63.6%) varied substantially. The prevalences of cephalosporin-susceptible E. coli and K. pneumoniae were higher in the northeastern and southern regions than in the central and eastern regions, reflecting the ESBL-positive rates in these areas, and were lowest in the Jiangsu-Zhejiang (Jiang-Zhe) area where the rates of carbapenem resistance were also highest. Ertapenem, amikacin, piperacillin-tazobactam, and imipenem are the most efficacious antibiotics for treating IAIs in China, especially those caused by E. coli or K. pneumoniae. Resistance to cephalosporins and carbapenems is more common in the Jiang-Zhe area than in other regions in China.
机译:为了评估2012年至2013年间在中国导致医院获得和社区获得的腹腔内感染(IAIs)的革兰氏阴性杆菌的抗菌药敏性,我们确定了对12种抗菌药和超广谱β-内酰胺酶(ESBL)的敏感性)使用CLSI肉汤微稀释液和解释性标准,在中央实验室中对来自中国七个地理区域的3,540个IAI分离物的状态进行了分析。大多数感染是由大肠杆菌(46.3%)和肺炎克雷伯菌(19.7%)引起的。在医院获得的IAI中,产生ESBL的大肠杆菌(P = 0.031),肺炎克雷伯菌(P = 0.017)和奇异变形杆菌(P = 0.004)的发生率高于社区获得的IAI。肠杆菌科细菌对ertapenem,阿米卡星,哌拉西林-他唑巴坦和亚胺培南的敏感性分别为71.3%至100%,81.3%至100%,64.7%至100%和83.1%至100%,但是亚胺培南对米氏疟原虫无效。 (<20%)。尽管大多数ESBL阳性医院获得的分离株对第三代和第四代头孢菌素都有抗药性,但大多数对头孢西丁敏感(47.9%至83.9%)。 ESBL阳性分离株对氨苄西林舒巴坦(<10%)的敏感性较低,而对环丙沙星(0%至54.6%)和左氧氟沙星(0%至63.6%)的敏感性差异很大。东北和南部地区的头孢菌素敏感性大肠杆菌和肺炎克雷伯菌的患病率高于中部和东部地区,反映了这些地区的ESBL阳性率,而在江浙地区最低(江西省)。这是碳青霉烯耐药率最高的地区。厄他培南,阿米卡星,哌拉西林-他唑巴坦和亚胺培南是在中国治疗IAI的最有效抗生素,尤其是那些由大肠杆菌或肺炎克雷伯菌引起的抗生素。与中国其他地区相比,江浙地区对头孢菌素和碳青霉烯类药物的耐药性更为普遍。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号